Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CARNITOR 200 MG

LEVOCARNITINE : 200 MG · DIN 02144344 · LEADIANT BIOSCIENCES, INC

Health Canada status: MARKETED

What is CARNITOR?

CARNITOR 200 MG contains LEVOCARNITINE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02144344, held by LEADIANT BIOSCIENCES, INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 07-May-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is CARNITOR used for?

Primary systemic carnitine deficiency; secondary carnitine deficiency due to inborn errors of metabolism; prevention/treatment of carnitine deficiency in ESRD patients on dialysis (Injection only).

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02144344
Brand nameCARNITOR
Generic / active ingredientLEVOCARNITINE : 200 MG
ManufacturerLEADIANT BIOSCIENCES, INC
Strength200 MG
Dosage formSOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeA16AA01 LEVOCARNITINE
AHFS class92:92.00
BiosimilarNo
Health Canada statusMARKETED
Status date07-May-2018
Original market date1995-12-31 00:00:00

How is it administered?

Oral: 990 mg 2-3 times/day (tablets) or 1-3 g/day (solution). IV: 50 mg/kg bolus/infusion for metabolic disorders; 20 mg/kg post-dialysis for ESRD. Doses should be spaced evenly.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Injection: Compatible with 0.9% NaCl or Lactated Ringer's for 24h at 25°C. (Specific product storage not in text).

How is it supplied?

Not explicitly detailed in provided text summary (refers to section 17).

Contraindications

Hypersensitivity to levocarnitine or any ingredient in the formulation.

Warnings and precautions

Serious hypersensitivity (anaphylaxis, laryngeal edema, bronchospasm) reported. Seizures may occur in patients with or without pre-existing activity. Oral solution contains sucrose.

What can be used instead?

Other Canadian products sharing ATC code A16AA01 LEVOCARNITINE. 4 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
CARNITOR100 MGSOLUTIONLEADIANT BIOSCIENCES, INCMARKETEDDIN 02144336
CARNITOR330 MGTABLETLEADIANT BIOSCIENCES, INCMARKETEDDIN 02144328
ODAN LEVOCARNITINE100 MGSOLUTIONODAN LABORATORIES LTDMARKETEDDIN 02492105

Who else supplies LEVOCARNITINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. LEVOCARNITINE appears in 16 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for CARNITOR

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02144344. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.